Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly
Stroke is a major cause of both death and disability. However, there are no pharmacological treatments used in most countries other than recombinant tissue plasminogen activator, a thrombolytic, and this is only used in about 4% of patients presenting after an acute ischaemic stroke. One novel throm...
Saved in:
| Main Author: | |
|---|---|
| Format: | Revisão |
| Language: | English |
| Published: |
2007
|
| Online Access: | https://doi.org/10.1038/sj.bjp.0707594 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|